UmarFarooqMDMS, MBA, FASN

Nephrology • Hershey, PA

Acute Renal Failure, Chronic Renal Failure & Dialysis, Glomerular Disease, Hypertension

Associate Chief Medical Officer | Academic Nephrologist | Associate Professor | Clinical Trials | Educator

Join to view full profile

Dr. Farooq is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Farooq's full profile

Already have an account?

Office
1
Hershey, PA 17033

Summary

Dr. Umar Farooq is a nephrologist in Hershey, PA and is affiliated with Penn State Milton S. Hershey Medical Center. He received his medical degree from King Edward Medical University and has been in practice 16 years. He specializes in chronic renal failure & dialysis, glomerular disease, hypertension, and kidney & pancreas transplantation and is experienced in hypertension, acute renal failure, transplant nephrology, chronic renal failure, and anemia of chronic kidney disease.

Mastering the Business of Health Care - Penn State Smeal Magazine

How two physicians and longtime friends turned to the Penn State Online MBA to enhance their leadership skills | By Jim Carlson

Education & Training

Penn State University College of MedicineMS, Public Health Sciences, 2009 - 2011
Penn State Milton S Hershey Medical CenterFellowship, Nephrology, 2008 - 2010
UPMC Medical EducationResidency, Internal Medicine, 2005 - 2008
King Edward Medical UniversityClass of 2001

Certifications & Licensure

PA State Medical License 2005 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
American society of hypertensionHypertension Specialist

Clinical Trials

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease Start of enrollment: 2015 Sep 17
Completed
Phase 3
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease Start of enrollment: 2015 Sep 17
Completed
Phase 3
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation Start of enrollment: 2016 Dec 01
Completed
Phase 4
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy Start of enrollment: 2021 Jun 25
Active, not recruiting
Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function Start of enrollment: 2024 Apr 12
Recruiting
Phase 3
TARGET BP I Clinical Trial Start of enrollment: 2019 Jul 22
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

21 citations
The outcomes of simultaneous liver and kidney transplantation using donation after cardiac death organs.
Tarek Alhamad, Christin Spatz, Tadahiro Uemura, Eric Lehman, Umar Farooq
Transplantation. 2014-12-15
1 citations
Native kidney pyelonephritis as the cause of recurrent urinary tract infections in a kidney transplant recipient
Erin K. Greenleaf, Umar Farooq, Ashokkumar Jain, Russell DiCristina, Zakiyah Kadry
Kidney International. 2018-03-01
14 citations
2014 Guideline for the Management of High Blood Pressure (Eighth Joint National Committee): Take-Home Messages
Umar Farooq, Sunita G. Ray
The Medical Clinics of North America. 2015-07-01